Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 328

1.

Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: a placebo-controlled clinical trial.

Geller DA, Hoog SL, Heiligenstein JH, Ricardi RK, Tamura R, Kluszynski S, Jacobson JG; Fluoxetine Pediatric OCD Study Team.

J Am Acad Child Adolesc Psychiatry. 2001 Jul;40(7):773-9.

PMID:
11437015
[PubMed - indexed for MEDLINE]
2.

Fluoxetine in children and adolescents with OCD: a placebo-controlled trial.

Liebowitz MR, Turner SM, Piacentini J, Beidel DC, Clarvit SR, Davies SO, Graae F, Jaffer M, Lin SH, Sallee FR, Schmidt AB, Simpson HB.

J Am Acad Child Adolesc Psychiatry. 2002 Dec;41(12):1431-8.

PMID:
12447029
[PubMed - indexed for MEDLINE]
3.

Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder.

Riddle MA, Scahill L, King RA, Hardin MT, Anderson GM, Ort SI, Smith JC, Leckman JF, Cohen DJ.

J Am Acad Child Adolesc Psychiatry. 1992 Nov;31(6):1062-9.

PMID:
1429406
[PubMed - indexed for MEDLINE]
4.

A randomized controlled clinical trial of citalopram versus fluoxetine in children and adolescents with obsessive-compulsive disorder (OCD).

Alaghband-Rad J, Hakimshooshtary M.

Eur Child Adolesc Psychiatry. 2009 Mar;18(3):131-5. doi: 10.1007/s00787-007-0634-z. Epub 2009 Feb 3.

PMID:
19190958
[PubMed - indexed for MEDLINE]
5.

Sertraline and fluoxetine treatment of obsessive-compulsive disorder: results of a double-blind, 6-month treatment study.

Bergeron R, Ravindran AV, Chaput Y, Goldner E, Swinson R, van Ameringen MA, Austin C, Hadrava V.

J Clin Psychopharmacol. 2002 Apr;22(2):148-54.

PMID:
11910259
[PubMed - indexed for MEDLINE]
6.

Fluvoxamine for children and adolescents with obsessive-compulsive disorder: a randomized, controlled, multicenter trial.

Riddle MA, Reeve EA, Yaryura-Tobias JA, Yang HM, Claghorn JL, Gaffney G, Greist JH, Holland D, McConville BJ, Pigott T, Walkup JT.

J Am Acad Child Adolesc Psychiatry. 2001 Feb;40(2):222-9.

PMID:
11211371
[PubMed - indexed for MEDLINE]
7.

Long-term sertraline treatment of children and adolescents with obsessive-compulsive disorder.

Cook EH, Wagner KD, March JS, Biederman J, Landau P, Wolkow R, Messig M.

J Am Acad Child Adolesc Psychiatry. 2001 Oct;40(10):1175-81.

PMID:
11589530
[PubMed - indexed for MEDLINE]
8.

Paroxetine treatment in children and adolescents with obsessive-compulsive disorder: a randomized, multicenter, double-blind, placebo-controlled trial.

Geller DA, Wagner KD, Emslie G, Murphy T, Carpenter DJ, Wetherhold E, Perera P, Machin A, Gardiner C.

J Am Acad Child Adolesc Psychiatry. 2004 Nov;43(11):1387-96.

PMID:
15502598
[PubMed - indexed for MEDLINE]
9.

A double-blind, placebo-controlled study of the efficacy and safety of controlled-release fluvoxamine in patients with obsessive-compulsive disorder.

Hollander E, Koran LM, Goodman WK, Greist JH, Ninan PT, Yang H, Li D, Barbato LM.

J Clin Psychiatry. 2003 Jun;64(6):640-7.

PMID:
12823077
[PubMed - indexed for MEDLINE]
10.

A double-blind, randomized, placebo-controlled trial of quetiapine addition in patients with obsessive-compulsive disorder refractory to serotonin reuptake inhibitors.

Denys D, de Geus F, van Megen HJ, Westenberg HG.

J Clin Psychiatry. 2004 Aug;65(8):1040-8.

PMID:
15323587
[PubMed - indexed for MEDLINE]
11.

Continuation treatment of OCD: double-blind and open-label experience with fluoxetine.

Tollefson GD, Birkett M, Koran L, Genduso L.

J Clin Psychiatry. 1994 Oct;55 Suppl:69-76; discussion 77-8.

PMID:
7961535
[PubMed - indexed for MEDLINE]
12.

Fluoxetine has no marked effect on tic symptoms in patients with Tourette's syndrome: a double-blind placebo-controlled study.

Scahill L, Riddle MA, King RA, Hardin MT, Rasmusson A, Makuch RW, Leckman JF.

J Child Adolesc Psychopharmacol. 1997 Summer;7(2):75-85.

PMID:
9334893
[PubMed - indexed for MEDLINE]
13.

Impact of comorbidity on treatment response to paroxetine in pediatric obsessive-compulsive disorder: is the use of exclusion criteria empirically supported in randomized clinical trials?

Geller DA, Biederman J, Stewart SE, Mullin B, Farrell C, Wagner KD, Emslie G, Carpenter D.

J Child Adolesc Psychopharmacol. 2003;13 Suppl 1:S19-29.

PMID:
12880497
[PubMed - indexed for MEDLINE]
14.

Long-term treatment of obsessive-compulsive disorder after an acute response: a comparison of fluoxetine versus placebo.

Romano S, Goodman W, Tamura R, Gonzales J.

J Clin Psychopharmacol. 2001 Feb;21(1):46-52.

PMID:
11199947
[PubMed - indexed for MEDLINE]
15.

An open trial and discontinuation study of fluoxetine in children and adolescents with obsessive-compulsive disorder.

Semerci ZB, Unal F.

Turk J Pediatr. 2001 Oct-Dec;43(4):323-8.

PMID:
11765163
[PubMed - indexed for MEDLINE]
16.

A 2-year study of sertraline in the treatment of obsessive-compulsive disorder.

Rasmussen S, Hackett E, DuBoff E, Greist J, Halaris A, Koran LM, Liebowitz M, Lydiard RB, McElroy S, Mendels J, O'Connor K.

Int Clin Psychopharmacol. 1997 Nov;12(6):309-16.

PMID:
9547132
[PubMed - indexed for MEDLINE]
17.

A double-blind, randomized, controlled trial of fluoxetine plus quetiapine or clomipramine versus fluoxetine plus placebo for obsessive-compulsive disorder.

Diniz JB, Shavitt RG, Fossaluza V, Koran L, Pereira CA, Miguel EC.

J Clin Psychopharmacol. 2011 Dec;31(6):763-8. doi: 10.1097/JCP.0b013e3182367aee.

PMID:
22020357
[PubMed - indexed for MEDLINE]
18.

Olanzapine augmentation for treatment-resistant obsessive-compulsive disorder.

Koran LM, Ringold AL, Elliott MA.

J Clin Psychiatry. 2000 Jul;61(7):514-7.

PMID:
10937610
[PubMed - indexed for MEDLINE]
19.

A 1 year double-blind placebo-controlled fixed dose study of sertraline in the treatment of obsessive-compulsive disorder.

Greist JH, Jefferson JW, Kobak KA, Chouinard G, DuBoff E, Halaris A, Kim SW, Koran L, Liebowtiz MR, Lydiard B, et al.

Int Clin Psychopharmacol. 1995 Jun;10(2):57-65.

PMID:
7673657
[PubMed - indexed for MEDLINE]
20.

A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder. The Lilly European OCD Study Group.

Montgomery SA, McIntyre A, Osterheider M, Sarteschi P, Zitterl W, Zohar J, Birkett M, Wood AJ.

Eur Neuropsychopharmacol. 1993 Jun;3(2):143-52.

PMID:
8364350
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk